BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 53444)

  • 1. A clinical service for prenatal diagnosis.
    Laxova R; Lewis BV; Suddaby M
    Lancet; 1975 Nov; 2(7942):964-6. PubMed ID: 53444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].
    Winter R
    Wien Klin Wochenschr; 1983 Feb; 95(3):67-78. PubMed ID: 6190319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum alpha-fetoprotein and fetal autosomal trisomies.
    Doran TA; Cadesky K; Wong PY; Mastrogiacomo C; Capello T
    Am J Obstet Gynecol; 1986 Feb; 154(2):277-81. PubMed ID: 2418684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ultrasound for placental localization in genetic amniocentesis.
    Miskin M; Doran TA; Rudd N; Gardner HA; Liedgren S; Benzie R
    Obstet Gynecol; 1974 Jun; 43(6):872-7. PubMed ID: 4829282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prenatal diagnosis. Review, personal and prospective studies].
    Engel E; Empson J; DeLozier D; McGee B; da Costa Woodson E; Engel-de Montmollin M; Carter T; Lorber C; Cassidy SB; Millis J; Heller RM; Boehm F; Vanhooydonk J
    Schweiz Med Wochenschr; 1979 Jul; 109(27):998-1010. PubMed ID: 88763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amniocentesis for prenatal genetic studies.
    Milunsky A; Atkins L; Littlefield JW
    Obstet Gynecol; 1972 Jul; 40(1):104-8. PubMed ID: 4261531
    [No Abstract]   [Full Text] [Related]  

  • 10. Results and pitfalls in prenatal cytogenetic diagnosis.
    Hsu LY; Dubin EC; Kerenyi T; Hirschhorn K
    J Med Genet; 1973 Jun; 10(2):112-9. PubMed ID: 4268389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early termination of anencephalic pregnancy after detection by raised alpha-fetoprotein levels.
    Seller MJ; Campbell S; Coltart TM; Singer JD
    Lancet; 1973 Jul; 2(7820):73. PubMed ID: 4123622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prenatal diagnosis of genetic defects from the amniotic fluid. Report of experiences].
    Körner H; Halle H; Wagenknecht C
    Zentralbl Gynakol; 1977; 99(12):725-34. PubMed ID: 70907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal cytogenetic screening.
    Simpson JL
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):3-5. PubMed ID: 7531607
    [No Abstract]   [Full Text] [Related]  

  • 14. The roles of ultrasonography and amniocentesis in evaluation of elevated maternal serum alpha-fetoprotein.
    Lindfors KK; Gorczyca DP; Hanson FW; Tennant FR; McGahan JP; Peterson AG
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1571-5; discussion 1575-6. PubMed ID: 1710874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
    Kaffe S; Hsu LY
    Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First experiences with amniocentesis from genetic indications].
    Kunz J; Schmid J; Schmid W; Schreiner WE
    Schweiz Med Wochenschr; 1975 Nov; 105(46):1525-32. PubMed ID: 56777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amniocentesis for antenatal diagnosis. A report on an initial series of 180 cases (author's transl)].
    Husslein P; Schnedl W; Wagenbichler P
    Wien Klin Wochenschr; 1979 Dec; 91(23):803-5. PubMed ID: 94482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.